✨ Free AI Report
China Resources Pharmaceutical Group Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research China Resources Pharmaceutical Group Limited
Company Research

China Resources Pharmaceutical Group Limited: Business Overview, Financials & Competitive Analysis

China Resources Pharmaceutical Group is an investment holding company engaged in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally, operati...

Analyst-debate audio for China Resources Pharmaceutical Group Limited

AskCyborg analysts argue the bull and bear cases for China Resources Pharmaceutical Group Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Defensive pharmaceutical play with integrated supply chain offering steady cash flow in growing Asian healthcare market despite...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing, Distribution & Retail
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest China Resources Pharmaceutical Group Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

China Resources Pharmaceutical Group Limited Overview

Pro stress-test →

China Resources Pharmaceutical Group is an investment holding company engaged in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally, operating through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company is the third largest drug distributor by revenue with strong presence in Eastern, Northern, and Southern China.

Strategic Profile

Pro stress-test →

The company offers a broad range of chemical drugs, Chinese medicines, and biological drugs across multiple therapeutic areas including cardiovascular, respiratory, orthopedic, and antitumor treatments. It provides warehousing, logistics, and pharmaceutical supply chain solutions to manufacturers, hospitals, distributors, and retail pharmacies.

Competitive Landscape

Pro stress-test →

As a vertically-integrated pharmaceutical conglomerate in mainland China's drug manufacturing, distribution, and retail sectors, the company competes with other major pharmaceutical distributors and manufacturers including regional players in Eastern, Northern, and Southern Chinese markets. Primary competitors include other large distributors and integrated pharmaceutical firms serving the rapidly consolidating Chinese healthcare sector.

Industry Context

China Resources Pharmaceutical Group Limited operates in Pharmaceutical Manufacturing, Distribution & Retail.

Key facts

Founded: 1938 · Headquarters: Wan Chai, Hong Kong · Employees: N/A · Revenue: N/A · Market cap: HK$31.1-31.2B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on China Resources Pharmaceutical Group Limited.

  • Vertically integrated model spanning manufacturing, distribution, and retail provides cost efficiency and supply chain control across mainland China
  • Third-largest pharmaceutical distributor by revenue signals significant market scale and established relationships with hospitals and medical institutions
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Current stock price HK$4.59-4.97 range with modest volatility and mixed technical signals
  • June 2025Market cap approximately HK$31-32 billion with 52-week trading range of HK$4.61-7.11
  • +1 moreTrack every material event for China Resources Pharmaceutical Group Limited as it happens. Explore monitoring →
Get alerted when China Resources Pharmaceutical Group Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pharmaceutical Distribution and ManufacturingChinese pharmaceutical distributor and manufacturer→Pharmaceutical Manufacturing and DistributionChinese pharmaceutical producer with distribution network→Integrated Pharmaceutical ServicesRegional competitors in manufacturing, distribution and retail→

Compare China Resources Pharmaceutical Group Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

China Resources Pharmaceutical Group Limited operates in Pharmaceutical Manufacturing, Distribution & Retail. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing, Distribution & Retail research →
NEW · MCP server

Ask your AI assistant about China Resources Pharmaceutical Group Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare China Resources Pharmaceutical Group Limited and its top competitor on Cyborg Score”
“What did China Resources Pharmaceutical Group Limited do this quarter?”
“Is China Resources Pharmaceutical Group Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does China Resources Pharmaceutical Group Limited do?+
China Resources Pharmaceutical Group is an investment holding company engaged in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally, operati...
What is China Resources Pharmaceutical Group Limited's Cyborg Score?+
China Resources Pharmaceutical Group Limited has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are China Resources Pharmaceutical Group Limited's main competitors?+
Named competitors include Pharmaceutical Distribution and Manufacturing, Pharmaceutical Manufacturing and Distribution, Integrated Pharmaceutical Services. The full competitive landscape is in the AskCyborg report.
How can I get the full China Resources Pharmaceutical Group Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the China Resources Pharmaceutical Group Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track China Resources Pharmaceutical Group Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.